deltatrials
Completed OBSERVATIONAL NCT04490668

Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery

Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery

Sponsor: Ruijin Hospital

Interventions Human albumin
Updated 4 times since 2020 Last updated: Jul 26, 2020 Started: Jan 1, 2016 Primary completion: Jul 31, 2018 Completion: Dec 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Anastomotic Leak and Gastric Cancer, this trial is completed. The trial is conducted by Ruijin Hospital and has accumulated 4 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Aug 2020 — Jan 2021 [monthly]

    Completed

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ruijin Hospital
Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.